Xlue raises $35 million to develop AI for identifying cancer risk

First reported by Forbes at · Updated · 2 sources

The Carnegie Mellon spinout has backing from Conviction, the venture capital firm founded by Sarah Guo, according to Forbes. RuntimeWire reports that Chenyan Xiong founded Xlue in 2025 and that Conviction led its seed round, supporting work to identify elevated cancer risk using patients’ longitudinal health records.

Covered by 2 publishers within 1 hour of the first report.

Reporting2

Forbes A Carnegie Mellon Researcher Raises $35 Million For Clinical Intelligence · Amy Feldman, Forbes Staff

Related